{"id":"https://openalex.org/W4416739655","doi":"https://doi.org/10.1158/1541-7786.30733028","title":"Supplementary Figure 1 from Simultaneous Targeting of DNA Polymerase Theta and PARP1 or RAD52 Triggers Dual Synthetic Lethality in Homologous Recombination\u2013Deficient Leukemia Cells","display_name":"Supplementary Figure 1 from Simultaneous Targeting of DNA Polymerase Theta and PARP1 or RAD52 Triggers Dual Synthetic Lethality in Homologous Recombination\u2013Deficient Leukemia Cells","publication_year":2025,"publication_date":"2025-11-27","ids":{"openalex":"https://openalex.org/W4416739655","doi":"https://doi.org/10.1158/1541-7786.30733028"},"language":"en","primary_location":{"id":"doi:10.1158/1541-7786.30733028","doi":"https://doi.org/10.1158/1541-7786.30733028","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.30733028","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Simultaneous_Targeting_of_DNA_Polymerase_Theta_and_PARP1_or_RAD52_Triggers_Dual_Synthetic_Lethality_in_Homologous_Recombination_Deficient_Leukemia_Cells/30733028/1/files/59894717.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Simultaneous_Targeting_of_DNA_Polymerase_Theta_and_PARP1_or_RAD52_Triggers_Dual_Synthetic_Lethality_in_Homologous_Recombination_Deficient_Leukemia_Cells/30733028/1/files/59894717.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019831669","display_name":"Katherine Sullivan-Reed","orcid":"https://orcid.org/0000-0001-9585-7848","observed_orcids":["https://orcid.org/0000-0001-9585-7848"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katherine Sullivan-Reed","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9585-7848","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038292704","display_name":"Monika Maria Toma","orcid":"https://orcid.org/0000-0001-8414-253X","observed_orcids":["https://orcid.org/0000-0001-8414-253X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monika M. Toma","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8414-253X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025976446","display_name":"Ma\u0142gorzata Drzewiecka","orcid":"https://orcid.org/0000-0002-5869-7993","observed_orcids":["https://orcid.org/0000-0002-5869-7993"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Malgorzata Drzewiecka","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5869-7993","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049450086","display_name":"Margaret Nieborowska-Skorska","orcid":"https://orcid.org/0009-0002-7798-1575","observed_orcids":["https://orcid.org/0009-0002-7798-1575"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Margaret Nieborowska-Skorska","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-7798-1575","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054895103","display_name":"Reza Nejati","orcid":"https://orcid.org/0000-0002-2188-156X","observed_orcids":["https://orcid.org/0000-0002-2188-156X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Reza Nejati","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2188-156X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073852871","display_name":"Adam Karami","orcid":"https://orcid.org/0009-0009-1448-9955","observed_orcids":["https://orcid.org/0009-0009-1448-9955"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam Karami","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-1448-9955","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062887811","display_name":"Mariusz A. Wasik","orcid":"https://orcid.org/0000-0002-1988-3670","observed_orcids":["https://orcid.org/0000-0002-1988-3670"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mariusz A. Wasik","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1988-3670","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066651403","display_name":"Tomasz \u015aliwi\u0144ski","orcid":"https://orcid.org/0000-0001-8385-7744","observed_orcids":["https://orcid.org/0000-0001-8385-7744"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomasz Sliwinski","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8385-7744","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5063022331","display_name":"Tomasz Sk\u00f3rski","orcid":"https://orcid.org/0000-0002-3809-4538","observed_orcids":["https://orcid.org/0000-0002-3809-4538"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomasz Skorski","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3809-4538","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9185000061988831,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9185000061988831,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.061900001019239426,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.006500000134110451,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dna-polymerase-theta","display_name":"DNA polymerase theta","score":0.8840000033378601},{"id":"https://openalex.org/keywords/parp-1","display_name":"PARP1","score":0.847000002861023},{"id":"https://openalex.org/keywords/rad52","display_name":"RAD52","score":1.0},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.9440000057220459},{"id":"https://openalex.org/keywords/homologous-recombination-deficiency","display_name":"homologous recombination deficiency","score":0.9860000014305115},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9810000061988831},{"id":"https://openalex.org/keywords/mrna-expression","display_name":"mRNA expression","score":0.5730000138282776},{"id":"https://openalex.org/keywords/genetic-alterations","display_name":"genetic alterations","score":0.9010000228881836}],"concepts":[{"id":"https://openalex.org/C2776630724","wikidata":"https://www.wikidata.org/wiki/Q18031020","display_name":"RAD52","level":5,"score":0.6388000249862671},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.607200026512146},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.559499979019165},{"id":"https://openalex.org/C2778480876","wikidata":"https://www.wikidata.org/wiki/Q21112674","display_name":"PARP1","level":5,"score":0.5512999892234802},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5074999928474426},{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.4837999939918518},{"id":"https://openalex.org/C2778502085","wikidata":"https://www.wikidata.org/wiki/Q7662767","display_name":"Synthetic lethality","level":4,"score":0.4740000069141388},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.44449999928474426},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.44209998846054077},{"id":"https://openalex.org/C64894306","wikidata":"https://www.wikidata.org/wiki/Q849622","display_name":"Homologous chromosome","level":3,"score":0.4359000027179718},{"id":"https://openalex.org/C2756471","wikidata":"https://www.wikidata.org/wiki/Q206286","display_name":"DNA polymerase","level":3,"score":0.42879998683929443},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.39579999446868896},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.374099999666214},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.3716000020503998},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.33970001339912415},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3107999861240387},{"id":"https://openalex.org/C20379349","wikidata":"https://www.wikidata.org/wiki/Q1720706","display_name":"Lethality","level":2,"score":0.31060001254081726},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2928999960422516},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.2784999907016754},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.27570000290870667},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2685999870300293},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.26420000195503235},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.26179999113082886}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1541-7786.30733028","doi":"https://doi.org/10.1158/1541-7786.30733028","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.30733028","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Simultaneous_Targeting_of_DNA_Polymerase_Theta_and_PARP1_or_RAD52_Triggers_Dual_Synthetic_Lethality_in_Homologous_Recombination_Deficient_Leukemia_Cells/30733028/1/files/59894717.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30733028","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Simultaneous_Targeting_of_DNA_Polymerase_Theta_and_PARP1_or_RAD52_Triggers_Dual_Synthetic_Lethality_in_Homologous_Recombination_Deficient_Leukemia_Cells/30733028","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1541-7786.30733028","doi":"https://doi.org/10.1158/1541-7786.30733028","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.30733028","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Simultaneous_Targeting_of_DNA_Polymerase_Theta_and_PARP1_or_RAD52_Triggers_Dual_Synthetic_Lethality_in_Homologous_Recombination_Deficient_Leukemia_Cells/30733028/1/files/59894717.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W4416739655.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4402783324","https://openalex.org/W4382010766","https://openalex.org/W4405054595","https://openalex.org/W7095423325","https://openalex.org/W2025329130","https://openalex.org/W4220676776","https://openalex.org/W2582344225","https://openalex.org/W2966053746","https://openalex.org/W4309610142","https://openalex.org/W2781127727"],"abstract_inverted_index":{"S1.":[0],"Genetic":[1],"aberrations":[2],"and":[3,10],"mRNA":[4],"expression":[5],"variabilities":[6],"of":[7],"POLQ,":[8],"PARP1":[9],"RAD52":[11],"do":[12],"not":[13],"coexist":[14],"in":[15],"519":[16],"AML":[17],"samples":[18],"from":[19],"the":[20],"BEAT-AML":[21],"cohort.":[22]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2025-11-28T00:00:00"}